Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schendzielorz

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
HNO|August 6, 2013
[Specific immunotherapy : clinical experience with recombinant molecular major allergens and hypoallergenic variants]P Schendzielorz, L Klimek
Laryngo- Rhino- Otologie|July 30, 2014
["58-year-old patient with painful, aphthous stomatitis and conjunctivitis"]P Schendzielorz, R Hagen, M Scheich
Laryngologie, Rhinologie, Otologie|November 1, 1985
[Accessory external ear in the oropharynx]P Schendzielorz, T Brusis, G Arnold
Digitale Bilddiagnostik|September 1, 1985
[Recurrent extensive pleomorphic adenoma (mixed tumor) of the submandibular gland--diagnosis and therapy]F E Zanella, P Schendzielorz, J Kubatova
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 23, 2012
Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety studyL Klimek, P Schendzielorz, R Pinol, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|September 1, 1986
[Real-time sonography in the diagnosis of neck cysts]F E Zanella, D Beyer, G Cornelius, et al.
HNO|October 16, 2013
[Immunotherapy of allergic rhinitis without allergens? : new options for immunomodulation by vaccination with virus-like particles and CpG motifs]L Klimek, J Willers, P Schendzielorz, et al.
HNO|July 13, 2021
[Erratum to: Needs and burdens of palliative care patients with advanced and/or metastatic head and neck tumors]C Roch, P Schendzielorz, A Scherzad, et al.
HNO|May 21, 2020
[Needs and burdens of palliative care patients with advanced and/or metastatic head and neck tumors]C Roch, P Schendzielorz, A Scherzad, et al.
Stem Cells International|July 5, 2016
Labeling Adipose-Derived Stem Cells with Hoechst 33342: Usability and Effects on Differentiation Potential and DNA DamageP Schendzielorz, K Froelich, K Rak, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
HNO|August 6, 2013
[Specific immunotherapy : clinical experience with recombinant molecular major allergens and hypoallergenic variants]P Schendzielorz, L Klimek
Laryngo- Rhino- Otologie|July 30, 2014
["58-year-old patient with painful, aphthous stomatitis and conjunctivitis"]P Schendzielorz, R Hagen, M Scheich
Laryngologie, Rhinologie, Otologie|November 1, 1985
[Accessory external ear in the oropharynx]P Schendzielorz, T Brusis, G Arnold
Digitale Bilddiagnostik|September 1, 1985
[Recurrent extensive pleomorphic adenoma (mixed tumor) of the submandibular gland--diagnosis and therapy]F E Zanella, P Schendzielorz, J Kubatova
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 23, 2012
Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety studyL Klimek, P Schendzielorz, R Pinol, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|September 1, 1986
[Real-time sonography in the diagnosis of neck cysts]F E Zanella, D Beyer, G Cornelius, et al.
HNO|October 16, 2013
[Immunotherapy of allergic rhinitis without allergens? : new options for immunomodulation by vaccination with virus-like particles and CpG motifs]L Klimek, J Willers, P Schendzielorz, et al.
HNO|July 13, 2021
[Erratum to: Needs and burdens of palliative care patients with advanced and/or metastatic head and neck tumors]C Roch, P Schendzielorz, A Scherzad, et al.
HNO|May 21, 2020
[Needs and burdens of palliative care patients with advanced and/or metastatic head and neck tumors]C Roch, P Schendzielorz, A Scherzad, et al.
Stem Cells International|July 5, 2016
Labeling Adipose-Derived Stem Cells with Hoechst 33342: Usability and Effects on Differentiation Potential and DNA DamageP Schendzielorz, K Froelich, K Rak, et al.
Pageof 2